HTFLHIGH SIGNALFINANCIAL10-Q

HTFL executed a major capital raise that dramatically improved its financial position, increasing cash by 263% to $291M while converting from a $895M stockholders deficit to $255M positive equity.

This represents a transformative financing event that has fundamentally strengthened HTFL's balance sheet and eliminated previous going concern risks. The company also demonstrated strong operational momentum with 57% revenue growth, though this came at the cost of significantly higher losses as R&D spending increased 60%.

Comparing 2025-11-12 vs 2025-09-19View on EDGAR →
FINANCIAL ANALYSIS

HTFL underwent a dramatic financial transformation, with cash increasing 263% to $291M and total assets more than doubling to $364M, while simultaneously converting from an $895M stockholders deficit to $255M positive equity through what appears to be a major equity raise or debt conversion. Revenue grew strongly at 57% to $127M with gross profit up 58%, but net losses more than doubled to $92M as the company significantly ramped R&D spending by 60% to $46M. The overall picture shows a company that has secured substantial funding to fuel aggressive growth investments, dramatically improving its financial stability while accepting higher near-term losses to drive expansion.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+263%
$80.2M$291.2M

Cash position surged 263% — strong cash generation or capital raise providing significant financial cushion.

Current Assets
Balance Sheet
+176.7%
$118.4M$327.8M

Current assets grew 176.7% — improving short-term liquidity or inventory/receivables build.

Total Assets
Balance Sheet
+128.7%
$159.4M$364.4M

Asset base grew 128.7% — expansion through organic growth, acquisitions, or capital deployment.

Stockholders Equity
Balance Sheet
+128.4%
-$894.8M$254.6M

Equity base grew 128.4% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Net Income
P&L
-122.4%
-$41.5M-$92.4M

Net income declined 122.4% — review whether driven by operations, interest costs, or non-recurring items.

Capital Expenditure
Cash Flow
+65.3%
$1.9M$3.1M

Capital expenditure jumped 65.3% — major investment cycle underway; assess returns on deployment.

Total Liabilities
Balance Sheet
-61.5%
$285.6M$109.8M

Liabilities reduced 61.5% — deleveraging improves balance sheet strength and financial flexibility.

R&D Expense
P&L
+59.7%
$29.0M$46.3M

R&D investment increased 59.7% — signals commitment to future product development, though near-term margin impact.

Gross Profit
P&L
+58.3%
$60.7M$96.1M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Revenue
P&L
+57.4%
$80.6M$126.9M

Strong top-line growth of 57.4% — accelerating demand or successful expansion into new markets.

LANGUAGE CHANGES
NEW — 2025-11-12
PRIOR — 2025-09-19
ADDED
Condensed Consolidated Financial Statements (unaudited) 4 Condensed Consolidated Balance Sheets 4 Condensed Consolidated Statements of Operations and Comprehensive Loss 5 Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders Equity (Deficit) 6 Condensed Consolidated Statements of Cash Flows 8 Notes to Condensed Consolidated Financial Statements 9 Item 2.
Condensed Consolidated Financial Statements (unaudited) Heartflow, Inc.
Condensed Consolidated Balance Sheets (in thousands, except share and per share amounts) (unaudited) September 30, December 31, 2025 2024 Assets Current assets: Cash and cash equivalents ........................................................................................................
$ 291,167 $ 51,367 Accounts receivable, net .............................................................................................................
27,858 24,639 Restricted cash, current ..............................................................................................................
+7 more — sign up free →
REMOVED
Condensed Consolidated Financial Statements 4 Condensed Consolidated Balance Sheets 4 Condensed Consolidated Statements of Operations and Comprehensive Loss 5 Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders Deficit 6 Condensed Consolidated Statements of Cash Flows 7 Notes to Condensed Consolidated Financial Statements 8 Item 2.
Condensed Consolidated Financial Statements HeartFlow Holding, Inc.
Condensed Consolidated Balance Sheets (in thousands, except share and per share amounts) (unaudited) June 30, December 31, 2025 2024 Assets Current assets: Cash and cash equivalents ...........................................................................................
$ 80,210 $ 51,367 Accounts receivable, net ...............................................................................................
29,687 24,639 Restricted cash, current ................................................................................................
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →